Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
Clinical trial NCT02690207 · COMPLETED
Trial details
- NCT number
- NCT02690207
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-16
- Primary completion
- 2019-03-15
- Enrollment
- 8687
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.